Skip to main content

An International Phase III Randomised Study to Evaluate the Efficacy of MTCE CEDIRANIB and OLAPARIB Combination Therapy or OLAPANB Alone in Patients with Relapsed Platinum-sensitive Ovarian Cancer Following a Response to Platinum-based Chemotherapy (ICON9)

Project Member(s): Viney, R., De Abreu Lourenco, R., Vargas Parada, C.

Funding or Partner Organisation: Cancer Research UK
Cancer Research UK

Start year: 2018

FOR Codes: Health Economics, Health Policy Economic Outcomes